Further, adiponectin improves insulin resistance in the liver and skeletal muscle via adenosine monophosphate-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-α (PPAR-α) activation [34]. Here, ADIPOQ is linked to Insulin resistance.